about
Are the physicochemical properties of antibacterial compounds really different from other drugs?Memoir: template-based structure prediction for membrane proteinsPlasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.Crowdsourcing yields a new standard for kinks in protein helices.Freely available conformer generation methods: how good are they?Reply to Y. TakefujiDwarna: a blockchain solution for dynamic consent in biobankingLigity: A Non-Superpositional, Knowledge-Based Approach to Virtual Screening
P50
Q27902251-14A9A60E-0488-4D1D-8E65-06BF83E76530Q30155100-00C84676-0EE2-4852-B9C3-2751365338ADQ36045121-4E4CACF5-B3AA-4E62-8F87-452F59AC2264Q45949703-FE11A9F2-3EC1-48DC-860A-DB703B17CC9CQ51386173-C1503296-B393-4D42-B38F-CDAA04D5EE93Q89983903-111F119E-09D1-4F57-893D-58A24A690991Q92025193-34853A47-A778-42DC-B500-C290B1928F16Q92221080-A3A5A369-D302-4CFF-8941-8F818783F0D6
P50
description
investigador
@es
researcher
@en
name
Jean-Paul Ebejer
@en
type
label
Jean-Paul Ebejer
@en
prefLabel
Jean-Paul Ebejer
@en
P31
P496
0000-0003-0888-2637